Work

A randomized, proof-of-concept clinical trial on repurposing chlorcyclizine for the treatment of chronic hepatitis C

Year: 2019

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Antiviral Research

DOI: 10.1016/j.antiviral.2019.01.017

Authors: Christopher Koh, Preeti Dubey, Ma Ai Thanda Han, Peter J. Walter, H. Martin Garraffo, Pallavi Surana, Noel T. Southall, Nathaniel Borochov, Susan L. Uprichard, Scott J. Cotler, Ohad Etzion, Theo Heller, Harel Dahari, T. Jake Liang

Institutions: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Loyola University Medical Center, Loyola University Chicago, Loyola Medicine, National Center for Advancing Translational Sciences

Language: English

Topic: Hepatitis C virus research

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, Centers for Disease Control and Prevention, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G2068881197, G2225345073, G230578209, HEPATITIS C COMMUNITY ALLIANCE FOR TESTING AND TREATMENT IN CHICAGO (HEPCCATT), G9000030679, G9000141398

OpenAlex ID: W2912257566

FWCI: 0.818

Cites: 29

Cited by: 10

Related to: 10